Over the past 6 years, Charles-Henri has worked extensively with French and international pharmaceutical companies, biotech companies and medical devices manufacturers in commercial litigation, product liability and group actions. He notably represents companies in mass litigation cases involving thousands of plaintiffs and has specific experience in complex product liability matters, particularly multi-jurisdiction bodily injury cases and the cross-border coordination these cases require. Charles-Henri works on a daily basis with colleagues within the firm; he was seconded to our London Litigation practice in 2013.
Charles-Henri is a senior associate in the Litigation practice of Hogan Lovells' Paris office and is a member of the firm's international life sciences team.
A graduate from Sciences Po Paris and HEC Paris business school, Charles-Henri understands the business objectives of our clients in this complex regulatory environment. Willing to offer practical solutions whenever they face new legal and business challenges, he is a member of several groups dedicated to the life sciences sector at our firm such as the False Advertising Group and the cross-disciplinary Digital Health team.
Charles-Henri is a member of the young lawyers committee of the association of defense counsel DRI International. He regularly publishes articles regarding both legal and procedural developments such as, recently, the introduction of class actions mechanisms in France.
In addition to his work, Charles-Henri is committed to the Pro Bono activities and citizenship initiatives of our Paris office.
Defending TÜV Rheinland against liability claims resulting from allegedly inappropriate certification of breast implant manufacturer P.I.P.
We assist the French pharmaceutical trade association on the bill introducing class actions in health-related matters into French law.
We defend a leading group in the healthcare industry in civil and administrative proceedings brought by patients with respect to blood-derived products and oncology treatments.
We defend a leading vaccine manufacturer in claims brought by patients before French Regional Commissions for Conciliation and Compensation (CCI).
We defend a medical devices distributor in ex parte and summary proceedings in an unfair competition claim.
We defend health products manufacturers with regard to pharmaceutical advertising and litigation.
We defend an orthopaedic devices manufacturer in an unfair competition claim and in product liability cases.
We defend a leading manufacturer in the scope of its defence to a product liability claim relating to medical device for the embolization of aneurysms.